| Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma J Martinez-Lopez, JJ Lahuerta, F Pepin, M González, S Barrio, R Ayala, ... Blood, The Journal of the American Society of Hematology 123 (20), 3073-3079, 2014 | 496 | 2014 |
| Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes KM Kortüm, EK Mai, NH Hanafiah, CX Shi, YX Zhu, L Bruins, S Barrio, ... Blood, The Journal of the American Society of Hematology 128 (9), 1226-1233, 2016 | 232 | 2016 |
| Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels TM Snyder, RM Gittelman, M Klinger, DH May, EJ Osborne, R Taniguchi, ... MedRxiv, 2020 | 185 | 2020 |
| A large-scale database of T-cell receptor beta (TCRβ) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2 S Nolan, M Vignali, M Klinger, JN Dines, IM Kaplan, E Svejnoha, T Craft, ... Research square, 2020 | 152 | 2020 |
| Spectrum and functional validation of PSMB5 mutations in multiple myeloma S Barrio, T Stühmer, M Da-Viá, C Barrio-Garcia, N Lehners, A Besse, ... Leukemia 33 (2), 447-456, 2019 | 112 | 2019 |
| Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome S Barrio, TD Shanafelt, J Ojha, KG Chaffee, C Secreto, KM Kortüm, ... Leukemia 31 (1), 170-176, 2017 | 75 | 2017 |
| Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients KM Kortuem, E Braggio, L Bruins, S Barrio, CS Shi, YX Zhu, R Tibes, ... Blood cancer journal 6 (2), e397-e397, 2016 | 65 | 2016 |
| Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma J Martinez-Lopez, B Sanchez-Vega, S Barrio, I Cuenca, Y Ruiz-Heredia, ... Leukemia 31 (6), 1446-1449, 2017 | 62 | 2017 |
| IKZF1/3 and CRL4CRBN E3 ubiquitin ligase mutations and resistance to immunomodulatory drugs in multiple myeloma S Barrio, U Munawar, YX Zhu, N Giesen, CX Shi, M Da Viá, R Sanchez, ... Haematologica 105 (5), e237, 2020 | 53 | 2020 |
| CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF‐MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous … MC Da Vià, AG Solimando, A Garitano‐Trojaola, S Barrio, U Munawar, ... The oncologist 25 (2), 112-118, 2020 | 48 | 2020 |
| Phenotypic, transcriptomic, and genomic features of clonal plasma cells in light-chain amyloidosis B Paiva, J Martinez-Lopez, LA Corchete, B Sanchez-Vega, I Rapado, ... Blood, The Journal of the American Society of Hematology 127 (24), 3035-3039, 2016 | 46 | 2016 |
| Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm S Barrio, M Gallardo, A Arenas, R Ayala, I Rapado, D Rueda, ... British journal of haematology 161 (5), 667-676, 2013 | 35 | 2013 |
| Epigenomic profiling in polycythaemia vera and essential thrombocythaemia shows low levels of aberrant DNA methylation S Barrio, M Gallardo, E Albizua, A Jimenez, I Rapado, R Ayala, F Gilsanz, ... Journal of clinical pathology 64 (11), 1010-1013, 2011 | 34 | 2011 |
| Cereblon enhancer methylation and IMiD resistance in multiple myeloma L Haertle, S Barrio, U Munawar, S Han, X Zhou, C Vogt, RA Fernández, ... Blood, The Journal of the American Society of Hematology 138 (18), 1721-1726, 2021 | 29 | 2021 |
| Proteomic analysis reveals heat shock protein 70 has a key role in polycythemia Vera M Gallardo, S Barrio, M Fernandez, A Paradela, A Arenas, O Toldos, ... Molecular Cancer 12, 1-12, 2013 | 25 | 2013 |
| Making clinical decisions based on measurable residual disease improves the outcome in multiple myeloma J Martinez-Lopez, R Alonso, SW Wong, R Rios, N Shah, Y Ruiz-Heredia, ... Journal of Hematology & Oncology 14, 1-4, 2021 | 22 | 2021 |
| The minimal residual disease using liquid biopsies in hematological malignancies R Colmenares, N Álvarez, S Barrio, J Martínez-López, R Ayala Cancers 14 (5), 1310, 2022 | 21 | 2022 |
| Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism array R García‐Sanz, LA Corchete, M Alcoceba, MC Chillon, C Jiménez, ... Hematological Oncology 35 (4), 746-751, 2017 | 21 | 2017 |
| Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients A Medina, C Jiménez, ME Sarasquete, M González, MC Chillón, ... Blood cancer journal 10 (2), 14, 2020 | 18 | 2020 |
| Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing Y Ruiz-Heredia, B Sánchez-Vega, E Onecha, S Barrio, R Alonso, ... haematologica 103 (11), e544, 2018 | 18 | 2018 |
